Cargando…

Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections

For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human immunodeficiency virus, cytomegalovirus, and hepatitis C v...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagioti, Eleni, Klenerman, Paul, Lee, Lian N., van der Burg, Sjoerd H., Arens, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820320/
https://www.ncbi.nlm.nih.gov/pubmed/29503649
http://dx.doi.org/10.3389/fimmu.2018.00276
_version_ 1783301340826435584
author Panagioti, Eleni
Klenerman, Paul
Lee, Lian N.
van der Burg, Sjoerd H.
Arens, Ramon
author_facet Panagioti, Eleni
Klenerman, Paul
Lee, Lian N.
van der Burg, Sjoerd H.
Arens, Ramon
author_sort Panagioti, Eleni
collection PubMed
description For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human immunodeficiency virus, cytomegalovirus, and hepatitis C virus. Currently, various promising prophylactic vaccines, capable of inducing substantial vaccine-specific T cell responses, are investigated in preclinical and clinical studies. There is compelling evidence that protection by T cells is related to the magnitude and breadth of the T cell response, the type and homing properties of the memory T cell subsets, and their cytokine polyfunctionality and metabolic fitness. In this review, we evaluated these key factors that determine the qualitative and quantitative properties of CD4(+) and CD8(+) T cell responses in the context of chronic viral disease and prophylactic vaccine development. Elucidation of the mechanisms underlying T cell-mediated protection against chronic viral pathogens will facilitate the development of more potent, durable and safe prophylactic T cell-based vaccines.
format Online
Article
Text
id pubmed-5820320
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58203202018-03-02 Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections Panagioti, Eleni Klenerman, Paul Lee, Lian N. van der Burg, Sjoerd H. Arens, Ramon Front Immunol Immunology For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human immunodeficiency virus, cytomegalovirus, and hepatitis C virus. Currently, various promising prophylactic vaccines, capable of inducing substantial vaccine-specific T cell responses, are investigated in preclinical and clinical studies. There is compelling evidence that protection by T cells is related to the magnitude and breadth of the T cell response, the type and homing properties of the memory T cell subsets, and their cytokine polyfunctionality and metabolic fitness. In this review, we evaluated these key factors that determine the qualitative and quantitative properties of CD4(+) and CD8(+) T cell responses in the context of chronic viral disease and prophylactic vaccine development. Elucidation of the mechanisms underlying T cell-mediated protection against chronic viral pathogens will facilitate the development of more potent, durable and safe prophylactic T cell-based vaccines. Frontiers Media S.A. 2018-02-16 /pmc/articles/PMC5820320/ /pubmed/29503649 http://dx.doi.org/10.3389/fimmu.2018.00276 Text en Copyright © 2018 Panagioti, Klenerman, Lee, van der Burg and Arens. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Panagioti, Eleni
Klenerman, Paul
Lee, Lian N.
van der Burg, Sjoerd H.
Arens, Ramon
Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
title Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
title_full Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
title_fullStr Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
title_full_unstemmed Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
title_short Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
title_sort features of effective t cell-inducing vaccines against chronic viral infections
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820320/
https://www.ncbi.nlm.nih.gov/pubmed/29503649
http://dx.doi.org/10.3389/fimmu.2018.00276
work_keys_str_mv AT panagiotieleni featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections
AT klenermanpaul featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections
AT leeliann featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections
AT vanderburgsjoerdh featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections
AT arensramon featuresofeffectivetcellinducingvaccinesagainstchronicviralinfections